162 related articles for article (PubMed ID: 4434446)
1. [Effect of glucagon on glucose and nonesterified fatty acids in chronic hepatic disease (author's transl)].
Malinovská V; Holík K
Cas Lek Cesk; 1974 Feb; 113(8):245-7. PubMed ID: 4434446
[No Abstract] [Full Text] [Related]
2. [Glycolipidemic variations during the double glucagon test in patients with liver diseases].
Sgambato S; Carbone L; Torella R; Frascolla N; Drammis E
G Clin Med; 1977; 58(7-8):301-11. PubMed ID: 924051
[No Abstract] [Full Text] [Related]
3. Studies on citrate metabolism in liver injuries. 1. Fasting blood citrate level in chronic hepatitis and liver cirrhosis.
Kaneshige J
Acta Med Okayama; 1975 Feb; 29(1):1-8. PubMed ID: 125999
[TBL] [Abstract][Full Text] [Related]
4. [Significance of serum triglycerides, nonesterified fatty acids and phospholipids in acute and chronic hepatitis].
Torjescu V; Ceauşu E; Văleanu M; Pîrvu D; Melencu M; Urcan M
Med Interna (Bucur); 1968 Jul; 20(7):817-23. PubMed ID: 5685312
[No Abstract] [Full Text] [Related]
5. [Hyperinsulinaemia and impaired glucose tolerance in chronic inflammatory liver disease (author's disease)].
Oehler G; Bleyl H; Knecht M; Matthes K
Z Gastroenterol; 1981 Jan; 19(1):26-32. PubMed ID: 7222867
[TBL] [Abstract][Full Text] [Related]
6. [Metabolic effect of administration of glucagon and a combination of glucagon and fructose to patients with cirrhosis of the liver and to healthy subjects (author's transl)].
Brodanová M; Brodan V; Andĕl M; Kuhn E
Sb Lek; 1976 Aug; 78(8):218-24. PubMed ID: 981947
[No Abstract] [Full Text] [Related]
7. [The relation between the dosage of glucagon and the response of some lipid parameters and glycemia in healthy individuals (author's transl)].
Andel M; Brodan V; Kuhn E
Cas Lek Cesk; 1976 Jun; 115(25):764-6. PubMed ID: 949723
[No Abstract] [Full Text] [Related]
8. [Study of the response of c-AMP, glucose and free fatty acids to stimulus with glucagon in rats in experimental hepatic cirrhosis].
Esteva Díaz F; Ducons García J; Ceña Lázaro G; Márquez Galván M; Barrao Comps F
Rev Clin Esp; 1987 Apr; 180(7):364-7. PubMed ID: 3037626
[No Abstract] [Full Text] [Related]
9. [Metabolic effect of glucagon in obese individuals. II. Effect on the levels of nonesterified fatty acids and beta-hydroxybutyric acid in the blood].
Beno I; Chorváthová V; Jurcovicová M
Cas Lek Cesk; 1983 Nov; 122(44):1360-3. PubMed ID: 6640603
[No Abstract] [Full Text] [Related]
10. [Reinvestigation of hyperglycemic response to glucagon and the effect of glucagon on blood cholesterol and triglyceride concentrations. (2) Changes in liver disease (author's transl)].
Okuno G; Kuroda K
Nihon Naibunpi Gakkai Zasshi; 1976 Dec; 52(12):1202-11. PubMed ID: 1031672
[No Abstract] [Full Text] [Related]
11. [Mathematical model of the decrease in the level of nonesterified fatty acids after glucose in healthy individuals and in cirrhotics].
Fabian E; Fabian F; Stork A; Kucerová L; Fabianová J
Sb Lek; 1971 Mar; 73(3):71-5. PubMed ID: 5555650
[No Abstract] [Full Text] [Related]
12. Effect of insulin and glycodiazine on the level of plasma free fatty acids in bilharzial (schistosomal) hepatic fibrosis.
Ghanem MH; Guirgis FK
J Trop Med Hyg; 1972 Jun; 75(6):115-8. PubMed ID: 5044326
[No Abstract] [Full Text] [Related]
13. [Effect of glucagon on the blood serum free fatty acids and glycerol in children].
Jablońska A; Spahn U
Pediatr Pol; 1970 Feb; 45(2):155-61. PubMed ID: 5437018
[No Abstract] [Full Text] [Related]
14. [The effect of glucagon on the serum levels of free fatty acids and glycerol in children].
Spahn U; Jablońska-Ulbrych A
Z Kinderheilkd; 1969; 106(3):213-24. PubMed ID: 5797236
[No Abstract] [Full Text] [Related]
15. [Free and esterified fatty acids in acute and chronic liver diseases].
Martinelli M; Disertori M; Montero C
Schweiz Med Wochenschr; 1970 Oct; 100(40):1701-2. PubMed ID: 5524982
[No Abstract] [Full Text] [Related]
16. The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output.
Everett-Grueter C; Edgerton DS; Donahue EP; Vaughan S; Chu CA; Sindelar DK; Cherrington AD
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E449-59. PubMed ID: 16608886
[TBL] [Abstract][Full Text] [Related]
17. [Effect of glucagon and of the glucose tolerance test on incretion of the somatotrophic hormone in normal subjects. Comparison of results].
Giordano G; Marugo M; Minuto F; Barreca T
Folia Endocrinol; 1971; 24(3):289-97. PubMed ID: 5171731
[No Abstract] [Full Text] [Related]
18. [Metabolic effect of glucagon in chronic cardiac insufficiency].
Franke F; Berchthold P; Simon H
Med Welt; 1972 Oct; 23(41):1421-3. PubMed ID: 5087189
[No Abstract] [Full Text] [Related]
19. Plasma insulin response to oral glucose load in hepatic cirrhosis.
Jain AK; Agarwal BK; Bajpai HS; Gupta JP
Indian J Med Res; 1983 Sep; 78():388-94. PubMed ID: 6370851
[No Abstract] [Full Text] [Related]
20. [Changes of glycemia, insulinemia (IRI), and non-esterified free fatty acids during dynamic tests in a group of subjects with hepatic cirrhosis. The Rastinon test].
Zandomeneghi R
Minerva Med; 1970 Jan; 61(6):185-9. PubMed ID: 5412764
[No Abstract] [Full Text] [Related]
[Next] [New Search]
